Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Sledge

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Blood|July 1, 1988
Analysis of phorbol ester stimulated human megakaryocyte developmentB J Roth, G W Sledge, J E Straneva, et al.
Advances in Enzyme Regulation|January 1, 1995
Regulation of signal transductionG Weber, R L Singhal, N Prajda, et al.
Blood Cells, Molecules & Diseases|June 6, 1998
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancerH E Broxmeyer, A Orazi, N L Hague, et al.
Cancer|July 15, 1991
Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the Hoosier Oncology GroupB J Roth, G W Sledge, S D Williams, et al.
Cancer Research|April 1, 1986
Establishment in long term culture of megakaryocytic leukemia cells (EST-IU) from the marrow of a patient with leukemia and a mediastinal germ cell neoplasmG W Sledge, M Glant, J Jansen, et al.
Progress in Clinical and Biological Research|January 1, 1986
Initial characterization of a human megakaryocytic leukemia cell line, EST-IUG W Sledge, B J Roth, N A Heerema, et al.
Blood Cells|January 1, 1986
Lactoferrin: affinity purification from human milk and polymorphonuclear neutrophils using monoclonal antibody (II 2C) to human lactoferrin, development of an immunoradiometric assay using II 2C, and myelopoietic regulation and receptor-binding characteristicsH E Broxmeyer, D C Bicknell, S Gillis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survivalK D Miller, T Weathers, L G Haney, et al.
Cancer Genetics and Cytogenetics|October 17, 1998
Characterization of multiple 12p rearrangements in testicular germ cell tumor cell line 833K and its subclone 64CP by chromosome microdissectionR I Blough, G H Vance, O Henegariu, et al.
Obstetrics and Gynecology|September 1, 1985
Presence of an estrogen-regulated protein in endometrial cancerG W Sledge, I Ramzy, L G Dressler, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Blood|July 1, 1988
Analysis of phorbol ester stimulated human megakaryocyte developmentB J Roth, G W Sledge, J E Straneva, et al.
Advances in Enzyme Regulation|January 1, 1995
Regulation of signal transductionG Weber, R L Singhal, N Prajda, et al.
Blood Cells, Molecules & Diseases|June 6, 1998
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancerH E Broxmeyer, A Orazi, N L Hague, et al.
Cancer|July 15, 1991
Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the Hoosier Oncology GroupB J Roth, G W Sledge, S D Williams, et al.
Cancer Research|April 1, 1986
Establishment in long term culture of megakaryocytic leukemia cells (EST-IU) from the marrow of a patient with leukemia and a mediastinal germ cell neoplasmG W Sledge, M Glant, J Jansen, et al.
Progress in Clinical and Biological Research|January 1, 1986
Initial characterization of a human megakaryocytic leukemia cell line, EST-IUG W Sledge, B J Roth, N A Heerema, et al.
Blood Cells|January 1, 1986
Lactoferrin: affinity purification from human milk and polymorphonuclear neutrophils using monoclonal antibody (II 2C) to human lactoferrin, development of an immunoradiometric assay using II 2C, and myelopoietic regulation and receptor-binding characteristicsH E Broxmeyer, D C Bicknell, S Gillis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survivalK D Miller, T Weathers, L G Haney, et al.
Cancer Genetics and Cytogenetics|October 17, 1998
Characterization of multiple 12p rearrangements in testicular germ cell tumor cell line 833K and its subclone 64CP by chromosome microdissectionR I Blough, G H Vance, O Henegariu, et al.
Obstetrics and Gynecology|September 1, 1985
Presence of an estrogen-regulated protein in endometrial cancerG W Sledge, I Ramzy, L G Dressler, et al.
Pageof 12